Alkermes Total Assets 2006-2020 | ALKS

Alkermes total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Alkermes Annual Total Assets
(Millions of US $)
2019 $1,805
2018 $1,825
2017 $1,797
2016 $1,726
2015 $1,856
2014 $1,919
2013 $1,578
2013 $1,470
2012 $1,435
2011 $452
2010 $516
2009 $566
2008 $656
2007 $569
2006 $477
2005 $339
Alkermes Quarterly Total Assets
(Millions of US $)
2020-06-30 $1,802
2020-03-31 $1,826
2019-12-31 $1,805
2019-09-30 $1,758
2019-06-30 $1,752
2019-03-31 $1,757
2018-12-31 $1,825
2018-09-30 $1,761
2018-06-30 $1,751
2018-03-31 $1,737
2017-12-31 $1,797
2017-09-30 $1,748
2017-06-30 $1,731
2017-03-31 $1,730
2016-12-31 $1,726
2016-09-30 $1,707
2016-06-30 $1,785
2016-03-31 $1,795
2015-12-31 $1,856
2015-09-30 $1,881
2015-06-30 $1,915
2015-03-31 $1,925
2014-12-31 $1,919
2014-09-30 $1,838
2014-06-30 $1,858
2014-03-31 $1,835
2013-12-31 $1,578
2013-09-30 $1,512
2013-06-30 $1,478
2013-03-31 $1,470
2012-12-31 $1,412
2012-09-30 $1,371
2012-06-30 $1,446
2012-03-31 $1,435
2011-12-31 $1,506
2011-09-30 $1,504
2011-06-30 $451
2011-03-31 $452
2010-12-31 $447
2010-09-30 $449
2010-06-30 $492
2010-03-31 $516
2009-12-31 $520
2009-09-30 $527
2009-06-30 $535
2009-03-31 $566
2008-12-31 $597
2008-09-30 $605
2008-06-30 $649
2008-03-31 $656
2007-12-31 $730
2007-09-30 $573
2007-06-30 $564
2007-03-31 $569
2006-12-31 $563
2006-09-30 $544
2006-06-30 $558
2006-03-31 $477
2005-12-31 $483
2005-09-30 $489
2005-06-30 $487
2005-03-31 $339
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.448B $1.171B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $130.693B 10.06
Amgen (AMGN) United States $126.732B 13.17
CSL (CSLLY) Australia $93.560B 0.00
Gilead Sciences (GILD) United States $73.619B 9.79
Regeneron Pharmaceuticals (REGN) United States $60.329B 23.07
Vertex Pharmaceuticals (VRTX) United States $54.266B 30.28
Illumina (ILMN) United States $45.215B 52.58
Biogen (BIIB) United States $37.587B 6.68
Seattle Genetics (SGEN) United States $33.903B 0.00
BeiGene (BGNE) Cayman Islands $27.121B 0.00
Moderna (MRNA) United States $25.940B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.172B 10.49
Genmab (GMAB) Denmark $22.053B 13.91
Genmab (GNMSF) Denmark $21.028B 4.84
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.298B 0.00
Exact Sciences (EXAS) United States $19.182B 0.00
Incyte (INCY) United States $19.025B 0.00
BioNTech SE (BNTX) Germany $17.544B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Horizon Therapeutics Public (HZNP) Ireland $15.951B 37.32
Alnylam Pharmaceuticals (ALNY) United States $14.482B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.491B 97.88
ARGENX SE-ADR (ARGX) Netherlands $11.956B 0.00
MyoKardia (MYOK) United States $11.809B 0.00
QIAGEN (QGEN) Netherlands $11.089B 24.97
Sarepta Therapeutics (SRPT) United States $11.017B 0.00
Guardant Health (GH) United States $10.986B 0.00
Bio-Techne Corp (TECH) United States $9.934B 68.16
Mirati Therapeutics (MRTX) United States $9.008B 0.00
Repligen (RGEN) United States $8.988B 142.67
Ascendis Pharma (ASND) Denmark $8.511B 0.00
Galapagos (GLPG) Belgium $7.880B 28.51
ACADIA Pharmaceuticals (ACAD) United States $7.320B 0.00
Adaptive Biotechnologies (ADPT) United States $6.924B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.646B 0.00
Exelixis (EXEL) United States $6.473B 23.54
Acceleron Pharma (XLRN) United States $6.359B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.799B 0.00
Blueprint Medicines (BPMC) United States $5.783B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.454B 14.90
Novavax (NVAX) United States $4.984B 0.00
Denali Therapeutics (DNLI) United States $4.890B 0.00
Emergent Biosolutions (EBS) United States $4.830B 19.13
Arena Pharmaceuticals (ARNA) United States $4.808B 0.00
Amicus Therapeutics (FOLD) United States $4.725B 0.00
China Biologic Products (CBPO) China $4.558B 27.06
NeoGenomics (NEO) United States $4.401B 1328.33
Vir Biotechnology (VIR) United States $4.204B 0.00
Halozyme Therapeutics (HALO) United States $3.964B 0.00
Reata Pharmaceuticals (RETA) United States $3.928B 0.00
Fate Therapeutics (FATE) United States $3.911B 0.00
Insmed (INSM) United States $3.572B 0.00
Twist Bioscience (TWST) United States $3.553B 0.00
Bluebird Bio (BLUE) United States $3.476B 0.00
Legend Biotech (LEGN) United States $3.341B 0.00
Global Blood Therapeutics (GBT) United States $3.309B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.276B 0.00
MorphoSys AG (MOR) Germany $3.264B 42.78
Eidos Therapeutics (EIDX) United States $2.779B 0.00
PHARMA MAR SA (PHMMF) Spain $2.348B 0.00
I-Mab (IMAB) China $2.337B 0.00
Seres Therapeutics (MCRB) United States $2.220B 0.00
Editas Medicine (EDIT) United States $1.968B 0.00
Beam Therapeutics (BEAM) United States $1.868B 0.00
Sorrento Therapeutics (SRNE) United States $1.856B 0.00
Amarin (AMRN) Ireland $1.834B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.832B 0.00
Inovio Pharmaceuticals (INO) United States $1.829B 0.00
Zymeworks (ZYME) Canada $1.820B 0.00
Viela Bio (VIE) United States $1.781B 0.00
UniQure (QURE) Netherlands $1.729B 0.00
Revance Therapeutics (RVNC) United States $1.717B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.616B 18.10
Intra-Cellular Therapies (ITCI) United States $1.571B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.564B 0.00
Sangamo Therapeutics (SGMO) United States $1.526B 0.00
Intellia Therapeutics (NTLA) United States $1.433B 0.00
Ligand Pharmaceuticals (LGND) United States $1.357B 45.88
Arcus Biosciences (RCUS) United States $1.331B 0.00
Zealand Pharma (ZEAL) Denmark $1.304B 0.00
Scholar Rock Holding (SRRK) United States $1.297B 0.00
Epizyme (EPZM) United States $1.260B 0.00
Alcobra (ARCT) United States $1.241B 0.00
Coherus BioSciences (CHRS) United States $1.224B 7.14
Mesoblast (MESO) Australia $1.222B 0.00
Mersana Therapeutics (MRSN) United States $1.202B 0.00
NGM Biopharmaceuticals (NGM) United States $1.193B 0.00
Zealand Pharma (ZLDPF) Denmark $1.191B 0.00
Cytokineticsorporated (CYTK) United States $1.082B 0.00
Retrophin (RTRX) United States $1.070B 0.00
REGENXBIO (RGNX) United States $1.063B 0.00
Heska (HSKA) United States $1.058B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.001B 0.00
Myriad Genetics (MYGN) United States $1.000B 0.00
Genetron Holdings (GTH) China $0.977B 0.00
Castle Biosciences (CSTL) United States $0.971B 0.00
Northwest Biotherapeutics (NWBO) United States $0.965B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.949B 0.00
Adverum Biotechnologies (ADVM) United States $0.928B 0.00
Athenex (ATNX) United States $0.927B 0.00
Compugen (CGEN) Israel $0.915B 0.00
Vericel (VCEL) United States $0.884B 0.00
Arvinas (ARVN) United States $0.828B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.823B 0.00
Morphic Holding (MORF) United States $0.807B 0.00
NantKwest (NK) United States $0.805B 0.00
Codexis (CDXS) United States $0.802B 0.00
AnaptysBio (ANAB) United States $0.782B 0.00
Alector (ALEC) United States $0.770B 0.00
Frequency Therapeutics (FREQ) United States $0.738B 0.00
Pliant Therapeutics (PLRX) United States $0.737B 0.00
Intrexon (PGEN) United States $0.733B 0.00
Cellectis S.A (CLLS) France $0.708B 0.00
Pharming Group (PHGUF) Netherlands $0.688B 15.71
Syndax Pharmaceuticals (SNDX) United States $0.684B 0.00
Protagonist Therapeutics (PTGX) United States $0.681B 0.00
Agenus (AGEN) United States $0.677B 0.00
MiMedx (MDXG) United States $0.644B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Cara Therapeutics (CARA) United States $0.620B 0.00
Celldex Therapeutics (CLDX) United States $0.601B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Kadmon Holdings (KDMN) United States $0.574B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.572B 0.00
Geron (GERN) United States $0.556B 0.00
VBI Vaccines (VBIV) United States $0.555B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.551B 28.01
IVERIC Bio (ISEE) United States $0.533B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.513B 0.00
MeiraGTx Holdings (MGTX) United States $0.496B 0.00
Albireo Pharma (ALBO) United States $0.483B 0.00
Cel-Sci (CVM) United States $0.476B 0.00
Anika Therapeutics (ANIK) United States $0.474B 20.71
ZIOPHARM Oncology Inc (ZIOP) United States $0.473B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.473B 0.00
MannKind (MNKD) United States $0.461B 0.00
Sutro Biopharma (STRO) United States $0.460B 0.00
Clovis Oncology (CLVS) United States $0.459B 0.00
UROGEN PHARMA (URGN) United States $0.458B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.458B 0.00
Prothena (PRTA) Ireland $0.450B 0.00
Amryt Pharma (AMYT) United Kingdom $0.446B 0.00
Avid Bioservices (CDMO) United States $0.428B 0.00
Starpharma Holdings (SPHRY) Australia $0.411B 0.00
Dynavax Technologies (DVAX) United States $0.411B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.409B 0.00
Merus (MRUS) Netherlands $0.378B 0.00
Kala Pharmaceuticals (KALA) United States $0.373B 0.00
Puma Biotechnology (PBYI) United States $0.361B 0.00
Selecta Biosciences (SELB) United States $0.360B 0.00
Cellular Biomedicine (CBMG) United States $0.354B 0.00
Cardiff Oncology (CRDF) United States $0.346B 0.00
Cue Biopharma (CUE) United States $0.344B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.342B 0.00
Spero Therapeutics (SPRO) United States $0.341B 0.00
Precision BioSciences (DTIL) United States $0.341B 0.00
ANI Pharmaceuticals (ANIP) United States $0.336B 7.94
AC Immune SA (ACIU) Switzerland $0.336B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.332B 0.00
IBio (IBIO) United States $0.332B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.326B 0.00
Kamada (KMDA) Israel $0.322B 15.38
Athersys (ATHX) United States $0.322B 0.00
Forte Biosciences (FBRX) United States $0.321B 0.00
BioDelivery Sciences (BDSI) United States $0.318B 22.50
Trevena (TRVN) United States $0.313B 0.00
CytomX Therapeutics (CTMX) United States $0.310B 0.00
Innate Pharma S.A (IPHA) France $0.308B 0.00
Syros Pharmaceuticals (SYRS) United States $0.305B 0.00
ChromaDex (CDXC) United States $0.286B 0.00
NextCure (NXTC) United States $0.277B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.276B 0.00
WAVE Life Sciences (WVE) Singapore $0.272B 0.00
XOMA (XOMA) United States $0.265B 0.00
PDL BioPharma (PDLI) United States $0.248B 0.00
Affimed (AFMD) Germany $0.243B 0.00
Pluristem Therapeutics (PSTI) Israel $0.236B 0.00
Arbutus Biopharma (ABUS) United States $0.235B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.217B 0.00
TELA Bio (TELA) United States $0.211B 0.00
Dyadic (DYAI) United States $0.205B 0.00
Fortress Biotech (FBIO) United States $0.204B 0.00
HOOKIPA Pharma (HOOK) United States $0.204B 0.00
Verastem (VSTM) United States $0.195B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.183B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.181B 0.00
Five Prime Therapeutics (FPRX) United States $0.179B 0.00
ADMA Biologics Inc (ADMA) United States $0.178B 0.00
Liquidia Technologies (LQDA) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.160B 0.00
Aptinyx (APTX) United States $0.157B 0.00
Cerecor (CERC) United States $0.156B 0.00
DBV Technologies S.A (DBVT) France $0.152B 0.00
Biofrontera AG (BFRA) Germany $0.150B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Theratechnologies (THTX) Canada $0.149B 0.00
Kindred Biosciences (KIN) United States $0.148B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.146B 0.00
GENFIT S.A (GNFT) France $0.146B 0.00
VolitionRX (VNRX) United States $0.143B 0.00
Bellus Health (BLU) Canada $0.143B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.142B 0.00
Checkpoint Therapeutics (CKPT) United States $0.140B 0.00
Applied Genetic Technologies (AGTC) United States $0.133B 0.00
Exicure (XCUR) United States $0.132B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.131B 6.10
AquaBounty Technologies (AQB) United States $0.128B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.126B 0.00
Unum Therapeutics (COGT) United States $0.125B 0.00
Catalyst Biosciences (CBIO) United States $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.123B 0.00
Prometic Life Sciences (LMNL) Canada $0.121B 0.00
Aytu Bioscience (AYTU) United States $0.120B 0.00
Cidara Therapeutics (CDTX) United States $0.119B 0.00
Lumos Pharma (LUMO) United States $0.119B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
Windtree Therapeutics (WINT) United States $0.111B 0.00
VTv Therapeutics (VTVT) United States $0.106B 0.00
Celyad SA (CYAD) Belgium $0.106B 0.00
Strongbridge Biopharma (SBBP) United States $0.104B 0.00
Gritstone Oncology (GRTS) United States $0.104B 0.00
Orgenesis (ORGS) United States $0.099B 5.02
Idera Pharmaceuticals (IDRA) United States $0.095B 0.00
Oncobiologics (OTLK) United States $0.094B 0.00
Antibe Therapeutics (ATBPF) Canada $0.094B 0.00
Abeona Therapeutics (ABEO) United States $0.092B 0.00
AIT Therapeutics (XAIR) United States $0.090B 0.00
Enzo Biochem (ENZ) United States $0.089B 0.00
Palatin Technologies (PTN) United States $0.088B 0.00
Ecology Coatings (ABVC) United States $0.085B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.080B 0.00
DiaMedica Therapeutics (DMAC) United States $0.078B 0.00
Cyclerion Therapeutics (CYCN) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.075B 0.00
Evogene (EVGN) Israel $0.074B 0.00
Stealth BioTherapeutics (MITO) United States $0.072B 69.50
Signal Genetics (MGEN) United States $0.071B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Prima BioMed (IMMP) Australia $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Synlogic (SYBX) United States $0.064B 0.00
Clearside Biomedical (CLSD) United States $0.064B 0.00
Organovo Holdings (ONVO) United States $0.062B 0.00
Curis (CRIS) United States $0.059B 0.00
Appili Therapeutics (APLIF) Canada $0.058B 0.00
Edesa Biotech (EDSA) Canada $0.057B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
AmpliPhi Biosciences (ARMP) United States $0.056B 0.00
TRACON Pharmaceuticals (TCON) United States $0.055B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.055B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.054B 0.00
Proteostasis Therapeutics (PTI) United States $0.053B 0.00
Biorestorative Therapies (BRTXQ) United States $0.052B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.051B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.044B 0.00
Genetic Technologies (GENE) Australia $0.043B 0.00
Happiness Biotech Group (HAPP) China $0.043B 0.00
Acorda Therapeutics (ACOR) United States $0.042B 0.00
Novogen (KZIA) Australia $0.041B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
IMMURON (IMRN) Australia $0.040B 0.00
AnPac Bio-Medical Science (ANPC) China $0.039B 0.00
Vaccinex (VCNX) United States $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Chanticleer Holdings (SONN) United States $0.036B 0.00
Apricus Biosciences (SEEL) United States $0.033B 0.00
Cleveland BioLabs (CBLI) United States $0.032B 0.00
ATyr Pharma (LIFE) United States $0.031B 0.00
OvaScience (MLND) United States $0.028B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.027B 0.00
BioCardia (BCDA) United States $0.025B 0.00
Advaxis (ADXS) United States $0.024B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
Alimera Sciences (ALIM) United States $0.021B 0.00
Prana Biotechnology (ATHE) Australia $0.021B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
Celsion (CLSN) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.018B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.016B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00